1don MSN
BRAF gene mutation leads to different therapeutic responses in melanoma and colorectal cancer
A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the ...
Morning Overview on MSN
Cancer treatment timing may matter more than you think, study says
Cancer care has long focused on what drugs to give and in what doses, but a growing body of evidence suggests the clock on ...
“PADCEVâ„¢ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of ...
Metastatic breast cancer treatment with the combination of PCS6422 and capecitabine (NGC-Cap) may increase the cancer-killing ...
Following cisplatin's success in the treatment of cancer, numerous other platinum-based complexes have been investigated as ...
When it comes to breast cancer, what specifically does early detection mean today -- and what do women often overlook about ...
DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...
News-Medical.Net on MSN
External signals control oncolytic bacteria for precise cancer therapy delivery
Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor ...
News-Medical.Net on MSN
Review highlights emerging role of tumor MHC-II in shaping cancer immunotherapy outcomes
Cancer immunotherapy has transformed cancer treatment, yet many patients experience limited or short-lived responses due to ...
MedPage Today on MSN
ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan (Trodelvy) failed to outperform chemotherapy as first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results